NCT04985344View on ClinicalTrials.gov

Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol

PHASE3RecruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
PTSD
Interventions
DRUG

Propranolol Oral Product

Child will receive oral propranolol (syrup). The dose of propranolol will increase gradually over the first 3 treatment sessions in order to assess tolerance.

DRUG

Placebo

Child will receive oral placebo (syrup). The dose of placebo will increase gradually over the first 3 treatment sessions in order to match propranolol intervention.

OTHER

memory reactivation

90 minutes after the propranolol take, a trained psychologist will ask the child to recount his trauma.

Trial Locations (1)

31059

RECRUITING

Toulouse University Hospital, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER